← All organizations
Sykehuset Innlandet HF
Academic/HospitalWebsite ↗
Also known as: Innlandet Hospital, Norway | Innlandet Hospital Trust Lillehammer | Innlandet Hospital Trust Lillehammer, Neurological Department | Innlandet Hospital Trust, Postboks 104, 2381 Brumunddal, Norway | Innlandet Hospital Trust, Reinsvoll | Innlandet Hospital Trust, Sanderud | Medi 3 Innlandet AS, avd Hamar | Sykehuset Innlandet HF | Tor A. Strand
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2001Last known activity
Jun 6, 2025
Timeline
2000s
- Jun 1, 2001
Sykehuset Innlandet HF— Founded
Drugs by trial phase (38 distinct, 26 trials)
Phase 4 (15 own, 0 via acquisition)
Phase 3 (12 own, 0 via acquisition)
Phase 2 (7 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
- Aggression
- Anemia
- Anemia, Iron-Deficiency
- Breast Neoplasms
- Bronchiolitis
- Dementia
- Depression, Postpartum
- Diarrhea
- Hepatitis
- Hepatitis A
- Hepatitis E
- Infections
- Irritable Bowel Syndrome
- Leg Ulcer
- Multiple Sclerosis
- Neutropenia
- Pneumonia
- Psychomotor Agitation
- Puerperal Disorders
- Sclerosis
- Ulcer
- Varicose Ulcer
- Vitamin B 12 Deficiency
Recent trials (31)
- NCT07040813CollaboratorPhase 3Jun 6, 2025
- NCT06270407CollaboratorPhase 4Oct 31, 2024
- NCT06119789CollaboratorPhase 2Nov 30, 2023
- NCT05137184CollaboratorPhase 3Nov 12, 2021
- NCT05005897Lead sponsorPhase 2/Phase 3Oct 15, 2021
- NCT05005897Overall official - principal investigatorPhase 2/Phase 3Oct 15, 2021
- NCT04817956CollaboratorPhase 2Apr 1, 2021
- NCT04121403CollaboratorPhase 3Oct 31, 2019
- NCT04870866CollaboratorPhase 2Jun 5, 2019
- NCT03646357CollaboratorPhase 4Oct 1, 2018
- NCT03071666CollaboratorPhase 2/Phase 3Mar 27, 2017
- NCT02759991CollaboratorPhase 4Jun 1, 2016
- NCT02599675CollaboratorN/ANov 1, 2015
- NCT02598830CollaboratorN/ANov 1, 2015
- NCT01587378CollaboratorN/AOct 1, 2012
Details
- Founded
- Brumunddal, NO Jun 1, 2001
- Last known activity
- Jun 6, 2025